Benzinga's Top #PreMarket Gainers

Loading...
Loading...
Opexa Therapeutics Inc OPXA
shares rose 36.55 percent to $0.526 in pre-market trading. On Tuesday, Maxim Group initiated coverage on Opexa Therapeutics with a Buy rating and a $5.00 price target.
Five Prime Therapeutics IncFPRX
shares surged 18.45 percent to $23.30 in pre-market trading on news that it has licensed certain antibodies to
Bluebird Bio Inc. BLUE
.
Tiffany & Co.TIF
gained 7.92 percent to $92.30 in pre-market trading after the company reported stronger-than-expected results for the first quarter on Wednesday.
Cellectis SA (ADR) CLLS
shares climbed 7.71 percent to $39.26 in pre-market trading after rising 7.21 percent on Tuesday.
TiVo Inc. TIVO
shares gained 4.73 percent to $10.85 in the pre-market trading session after the company reported upbeat results for the first quarter.
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...